Nasdaq: rvnc

See all ideas.

Revance Therapeutics, Inc. About the company. The company's lead drug candidate is DAXXIFY DaxibotulinumtoxinA-lanm for injection for the treatment of glabellar lines and cervical dystonia; has completed phase II clinical trials to treat upper facial lines, moderate or severe dynamic forehead lines, and moderate or severe lateral canthal lines; and has completed Phase II clinical trials for the treatment of adult upper limb spasticity and plantar fasciitis. Trading at Revenue is forecast to grow Trading at good value compared to peers and industry.

Nasdaq: rvnc

.

RVNC chart. What Revance Therapeutics, Inc.

.

Key events shows relevant news articles on days with large price movements. Karyopharm Therapeutics Inc. KPTI Evolus Inc. EOLS 1. Li Auto Inc. Minim Inc. MINM Zevra Therapeutics Inc.

Nasdaq: rvnc

We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service. ZacksTrade and Zacks. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. OK Cancel.

Pawn shop st jean

The company was founded by Jacob M. What is Revance Therapeutics, Inc. RVNC long rvnc - long consolidation and accumulation. Revenue to profit conversion. The company was founded by Jacob M. Revance Therapeutics, Inc. Who knows. Like other stocks, RVNC shares are traded on stock exchanges, e. Hollander as Chief Medical Officer Oct Second quarter earnings: EPS and revenues miss analyst expectations Aug The company's lead drug candidate is DAXXIFY DaxibotulinumtoxinA-lanm for injection for the treatment of glabellar lines and cervical dystonia; has completed phase II clinical trials to treat upper facial lines, moderate or severe dynamic forehead lines, and moderate or severe lateral canthal lines; and has completed Phase II clinical trials for the treatment of adult upper limb spasticity and plantar fasciitis. Watch for continuation and set a short stop. About Revance Therapeutics, Inc.

.

Show more. Apr Employees FY. Does Revance Therapeutics, Inc. TradeStation Featured. Revance Announces U. Consensus forecasts updated Nov Currently unprofitable and not forecast to become profitable over the next 3 years. Market capitalization. Mar Interactive Brokers. Hollander as Chief Medical Officer Oct